Powder: -20°C for 3 years | In solvent: -80°C for 1 year
HBX 41108 (HBX-41108) is a non-competitive, reversible inhibitor of USP7 with an IC50 of 424nM. HBX 41108 inhibited deubiquitination of p53 mediated by USP7 in a dose-dependent manner with an IC50 of 0.8μM.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 47.00 | |
2 mg | In stock | $ 68.00 | |
5 mg | In stock | $ 113.00 | |
10 mg | In stock | $ 189.00 | |
25 mg | In stock | $ 447.00 | |
50 mg | In stock | $ 659.00 | |
100 mg | In stock | $ 939.00 |
Description | HBX 41108 (HBX-41108) is a non-competitive, reversible inhibitor of USP7 with an IC50 of 424nM. HBX 41108 inhibited deubiquitination of p53 mediated by USP7 in a dose-dependent manner with an IC50 of 0.8μM. |
Targets&IC50 | USP7:424nM, p53:0.8μM |
Synonyms | HBX-41108 |
Molecular Weight | 266.64 |
Formula | C13H3ClN4O |
CAS No. | 924296-39-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 13 mg/mL
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
HBX 41108 924296-39-9 Apoptosis Cell Cycle/Checkpoint DNA Damage/DNA Repair Ubiquitination DUB p53 DUBs HBX-41108 inhibit Deubiquitinase Inhibitor HBX41108 inhibitor